CareDx
CDNA
63.04
-0.75
-1.18%
CareDx
US · CDNA
#2371 by market cap
Listed 1970
63.04
-0.75
-1.18%
Live - 5344 symbols - heartbeat 269s ago
· 2026-10-08 05:58
Pre-market
63.00
-0.06%
After-hours
63.00
-0.06%
Overnight
63.00
-0.06%
- Market cap
- 3.26B
- P/E (TTM)i
- 30.31
- P/Bi
- 7.66
- EPSi
- -0.40
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on CDNA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 4.8 percentage points.
Institutional ownership
- Held by institutions
- 101.17% -4.80pp
- Institutions
- 276 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund69.57%
Hedge Fund24.67%
Individual/Insider4.41%
Public Company3.46%
Private Company2.00%
Government Pension Fund0.86%
Family Office/Trust0.39%
Insurance Company0.21%
Top holders as of 2026-06-30
BlackRock
9.31% · 4.81M sh
Vanguard Capital Management, LLC
4.96% · 2.56M sh
State Street Global Advisors
4.77% · 2.47M sh
Deerfield Management Company, L.P.
3.86% · 2.00M sh
ARK Investment Management LLC
3.78% · 1.95M sh
Boston Partners Global Investors, Inc.
3.75% · 1.94M sh
Baron Capital Group, Inc.
3.74% · 1.94M sh
Gagnon Securities, LLC
3.15% · 1.63M sh
Chevy Chase Trust Company
2.78% · 1.44M sh
Geode Capital Management, LLC
2.57% · 1.33M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 12 buys · 38 sells
| Name | Role | Stake |
|---|---|---|
| John Hanna | Chief Executive Officer | 1.26% |
| Peter Maag | Executive Director | 0.57% |
| Abhishek Jain | Chief Financial Officer | 0.49% |
| Fred Cohen | Independent Director | 0.30% |
| Michael Goldberg | Independent Chairperson | 0.28% |
| George Bickerstaff | Independent Director | 0.24% |
| Jeffrey Novack | General Counsel | 0.21% |
| Keith Kennedy | Chief Operating Officer | 0.09% |
| William Hagstrom | Independent Director | 0.08% |
| Alexander Johnson | President of Patient and Testing Services | 0.08% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Michael Goldberg | Independent Chairperson | Other Acquisition | +588 | -- |
| 2026-09-30 | Keith Kennedy | Chief Operating Officer | Sale to Issuer | -3,018 | $66.23 |
| 2026-09-30 | John Hanna | Chief Executive Officer | Sale to Issuer | -8,511 | $66.23 |
| 2026-09-30 | Jessica Meng | Chief Commercial Officer | Sale to Issuer | -2,619 | $66.23 |
| 2026-09-30 | Jeffrey Novack | General Counsel | Sale to Issuer | -997 | $66.23 |
| 2026-09-11 | Keith Kennedy | Chief Operating Officer | Sale to Issuer | -8,220 | $52.37 |
| 2026-09-11 | Jessica Meng | Chief Commercial Officer | Sale to Issuer | -6,688 | $52.37 |
| 2026-08-16 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -9,122 | $46.38 |
| 2026-08-13 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -7,000 | $45.30 |
| 2026-08-12 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -7,000 | $47.07 |
| 2026-08-11 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -7,000 | $46.89 |
| 2026-08-10 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -7,000 | $47.69 |
| 2026-08-09 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -6,902 | $47.66 |
| 2026-08-04 | George Bickerstaff | Independent Director | Open Market Disposition | -20,000 | $46.29 |
| 2026-08-04 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -46,963 | $46.40 |
| 2026-08-04 | Jeffrey Novack | General Counsel | Automatic Disposition | -2,688 | $46.15–46.75 |
| 2026-08-03 | Michael Goldberg | Independent Chairperson | Open Market Disposition | -44,700 | $47.06 |
| 2026-08-03 | Christine Cournoyer | Independent Director | Open Market Disposition | -16,000 | $46.94 |
| 2026-08-03 | Peter Maag | Executive Director | Intent to Sell (Form 144) | -75,653 | $47.28 |
| 2026-07-31 | Jeffrey Novack | General Counsel | Sale to Issuer | -2,872 | $47.85 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:58:22 · For reference only, not investment advice and not tailored to your situation.